
Inhibrx Biosciences, Inc. (INBX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
127.58 - Open
125.00 - Bid 106.11 x 500
- Ask 114.10 x 500
- Day's Range
99.20 - 125.00 - 52 Week Range
10.84 - 155.29 - Volume
1,260,587 - Avg. Volume
370,131 - Market Cap (intraday)
1.587B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-9.04 - Earnings Date May 14, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
265.00
Recent News: INBX
View MorePerformance Overview: INBX
Trailing total returns as of 5/12/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: INBX
View MoreAnalyst Insights: INBX
View MoreStatistics: INBX
View MoreValuation Measures
-
Market Cap
1.96B
-
Enterprise Value
1.95B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.60k
-
Price/Book (mrq)
245.53
-
Enterprise Value/Revenue
1.50k
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-51.58%
-
Return on Equity (ttm)
-197.85%
-
Revenue (ttm)
1.3M
-
Net Income Avi to Common (ttm)
-140.06M
-
Diluted EPS (ttm)
-9.04
Balance Sheet and Cash Flow
-
Total Cash (mrq)
124.22M
-
Total Debt/Equity (mrq)
1,338.82%
-
Levered Free Cash Flow (ttm)
-84.46M
Compare To: INBX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.






